1
Clinical Trials associated with CARv3-TEAM-E T cells(Massachusetts General Hospital)INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs With GBM
The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with glioblastoma.
The name of the treatment intervention used in this research study is:
-CARv3-TEAM-E T Cells (or Autologous T lymphocytes).
Start Date22 Mar 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with CARv3-TEAM-E T cells(Massachusetts General Hospital)
100 Translational Medicine associated with CARv3-TEAM-E T cells(Massachusetts General Hospital)
100 Patents (Medical) associated with CARv3-TEAM-E T cells(Massachusetts General Hospital)
100 Deals associated with CARv3-TEAM-E T cells(Massachusetts General Hospital)